HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chikatapu Chandrasekhar Selected Research

Therapeutics

12/2021The randomized ZIPANGU trial of ranibizumab and adjunct laser for macular edema following branch retinal vein occlusion in treatment-naïve patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chikatapu Chandrasekhar Research Topics

Disease

3Macular Edema
10/2022 - 07/2021
3Retinal Vein Occlusion
10/2022 - 07/2021
1Vision Disorders (Hemeralopia)
12/2021

Drug/Important Bio-Agent (IBA)

3Ranibizumab (Lucentis)FDA Link
10/2022 - 07/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2022
1N-acetyltryptophanamide (NATA)IBA
12/2021

Therapy/Procedure

2Lasers (Laser)
12/2021 - 07/2021
1Injections
10/2022
1Therapeutics
12/2021